SCHEMBL22031246

SCHEMBL22031246

CC(C)n1cc(CN2C3CC2CN(C)C3)cn1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RET P07949 2/20 0.41
PDE8B O95263 1/20 0.39
KMT2A Q03164 4/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 2/20 0.36
ATM Q13315 1/20 0.36
ABL1 P00519 2/20 0.34
RIN1 Q13671 2/20 0.34
ALPL P05186 1/20 0.34
ALPI P09923 1/20 0.34
ALPG P10696 1/20 0.34
PARG Q86W56 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
OPRM1 P35372 1/20 0.32
OPRK1 P41145 1/20 0.32
ACHE P22303 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20149624 0.89 RET (0.41) RETPDE8BKMT2AMAPTALDH1A1
SCHEMBL21158720 0.86 RET (0.40) RETPDE8BKMT2AMAPTALDH1A1
SCHEMBL20148684 0.85 RET (0.43) RETPDE8BKMT2AMAPTALDH1A1
SCHEMBL20071330 0.85 RET (0.39) RETPDE8BKMT2AMAPTALDH1A1
SCHEMBL20071328 0.83 OPRM1 (0.42) RETALDH1A1OPRM1OPRK1
SCHEMBL20149633 0.78 OPRM1 (0.39) RETALDH1A1OPRM1OPRK1
SCHEMBL18080916 0.73 MAPT (0.46) RETPDE8BKMT2AMAPTALDH1A1
SCHEMBL20071347 0.72 RET (0.39) RETKMT2AMAPTALDH1A1MEN1
SCHEMBL22030755 0.71 RET (0.39) RET
SCHEMBL20148694 0.70 RET (0.40) RETALDH1A1OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3753939-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS Array Biopharma Inc. (US) 2020-12-23 EP disclosed
EP-3523301-B1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC (US) 2020-05-27 EP disclosed